Logo
x

Search

Subscribe Now

All Posts by Date

PharmaShots Interview: Eli Lilly's Marie Schiller Shares Insight on the Collaboration with Welldoc on New Version of BlueStar App

PharmaShots Interview: Eli Lilly's Marie Schiller Shares Insight on the Collaboration with Welldoc on New Version of BlueStar App

  • April 5, 2021
Merck KGaA Exercises Third Option in its Immuno-Oncology Collaboration with F- star

Merck KGaA Exercises Third Option in its Immuno-Oncology Collaboration with F- star

  • April 5, 2021
Gilead Expands its Collaboration with AbCellera to Develop Antibodies Against Multiple Indications

Gilead Expands its Collaboration with AbCellera to Develop Antibodies Against Multiple Indications

  • April 5, 2021
Taiho Oncology's Futibatinib (TAS-120) Receives the US FDA's Breakthrough Therapy Designation for Advanced Cholangiocarcinoma

Taiho Oncology's Futibatinib (TAS-120) Receives the US FDA's Breakthrough Therapy Designation for Advanced Cholangiocarcinoma

  • April 5, 2021
Lilly's Taltz (ixekizumab) Receives Health Canada's Approval for Pediatric Patients with Moderate to Severe Plaque Psoriasis

Lilly's Taltz (ixekizumab) Receives Health Canada's Approval for Pediatric Patients with Moderate to Severe Plaque Psoriasis

  • April 5, 2021
mAbxience's MB02 (biosimilar- bevacizumab) Receives EC's Approval for the Treatment of Cancer

mAbxience's MB02 (biosimilar- bevacizumab) Receives EC's Approval for the Treatment of Cancer

  • April 5, 2021
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.